Precision medicine
SPONSORED
|
10:06 am |
May 22, 2017
|
10:06 am |
May 22, 2017
In this podcast, we will review some of the ideas we shared in our previous podcasts on this series. We will also provide insights into what is new, what is driving the most current state of change and what we see as the next potential drivers.
Today’s IT infrastructures are not hearty enough to support the data needs of genomics and other emerging healthcare practices and capabilities, HIMSS Analytics says.
While healthcare is not applying the same kind of data understanding that other service rely on, precision medicine will bring that to the fore, expert says.
CRISPR has sparked considerable excitement for precision medicine, but patient safety, enzyme delivery and today’s level of disease understanding are limiting mainstream adoption.
An ambitious project aims to provide insight on “the most diverse collection of people in human history.”
Leonard, D’Avolio, Harvard professor and CEO of Cyft, sees a near future where artificial intelligence and machine learning will enable transformative improvements in healthcare. But it's important to have realistic understandings of their capabilities.
[Also: Politico uncovers more funding indiscretions from Patrick Soon-Shiong]Despite company losing $41 million in the first quarter, biotech mogul Patrick Soon-Shiong defended his company’s work and chastised what he called false reports.
New cancer test requires less DNA than previous versions.
While tests like those offered by 23andMe help patients become proactive in their healthcare, providers and the industry aren’t ready to interpret them.
Program has tapped internationally recognized bioinformatics and genomics expert to lead the effort.